[Drug induced pulmonary symptoms in medicine].
Mattila
M J
MJ
Department of Pharmacology and Toxicology, University of Helsinki, Finland.
D000638:Amiodarone / Q000009:adverse effects / Q000627:therapeutic use; D000666:Amphotericin B / Q000009:adverse effects / Q000627:therapeutic use; D016084:Bronchoconstriction; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D005387:Finland / Q000453:epidemiology; D006801:Humans; D015994:Incidence; D008171:Lung Diseases / Q000139:chemically induced* / Q000453:epidemiology*; D008297:Male; D009582:Nitrofurantoin / Q000009:adverse effects / Q000627:therapeutic use; D010396:Penicillamine / Q000009:adverse effects / Q000627:therapeutic use; D011014:Pneumonia / Q000139:chemically induced; D011654:Pulmonary Edema / Q000139:chemically induced; D018570:Risk Assessment; D020156:Salicylic Acid / Q000009:adverse effects / Q000627:therapeutic use
D000666:Amphotericin B; D009582:Nitrofurantoin; D010396:Penicillamine; D000638:Amiodarone; D020156:Salicylic Acid
Lääkkeiden haittavaikutukset hengitysteihin.